View the 50 largest pharmaceutical companies in the world listings here

Chiesi Farmaceutici

Rank: 44

2024 Revenues ($USD) : $3.69B

Chiesi Farmaceutici is a privately held, family-owned pharmaceutical company headquartered in Parma, Italy. Established in 1935, the company focuses on respiratory diseases, rare and ultra-rare conditions, and specialty care. In 2024, Chiesi reported consolidated revenues of €3.413 billion, marking a 13% increase at constant exchange rates compared to the previous year. The company's EBITDA surpassed €1 billion, with a margin close to 30%, and net profit reached €493 million. The respiratory segment, referred to as the "Air" franchise, remained the primary revenue contributor, accounting for €1.832 billion (54% of total revenue). The "Care" franchise, encompassing specialty care and consumer healthcare, generated €818 million (24%), while the "Global Rare Diseases" unit contributed €763 million (22%), driven by the integration of Amryt Pharma and the launch of new products in the U.S. market.